It has been reported that IRF2 inhibits cell proliferation by inducing CLDN7 upregulation in oral squamous cell carcinoma (39), and inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer (40). This evidence concerns the gene CLDN7 and cancer.